Literature DB >> 26980143

Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.

Danko Georgiev1, Toru Yoshihara2, Rika Kawabata1, Takurou Matsubara1, Makoto Tsubomoto1, Yoshio Minabe3, David A Lewis4, Takanori Hashimoto5.   

Abstract

In the cortex of subjects with schizophrenia, expression of glutamic acid decarboxylase 67 (GAD67), the enzyme primarily responsible for cortical GABA synthesis, is reduced in the subset of GABA neurons that express parvalbumin (PV). This GAD67 deficit is accompanied by lower cortical levels of other GABA-associated transcripts, including GABA transporter-1, PV, brain-derived neurotrophic factor (BDNF), tropomyosin receptor kinase B, somatostatin, GABAA receptor α1 subunit, and KCNS3 potassium channel subunit mRNAs. In contrast, messenger RNA (mRNA) levels for glutamic acid decarboxylase 65 (GAD65), another enzyme for GABA synthesis, are not altered. We tested the hypothesis that this pattern of GABA-associated transcript levels is secondary to the GAD67 deficit in PV neurons by analyzing cortical levels of these GABA-associated mRNAs in mice with a PV neuron-specific GAD67 knockout. Using in situ hybridization, we found that none of the examined GABA-associated transcripts had lower cortical expression in the knockout mice. In contrast, PV, BDNF, KCNS3, and GAD65 mRNA levels were higher in the homozygous mice. In addition, our behavioral test battery failed to detect a change in sensorimotor gating or working memory, although the homozygous mice exhibited increased spontaneous activities. These findings suggest that reduced GAD67 expression in PV neurons is not an upstream cause of the lower levels of GABA-associated transcripts, or of the characteristic behaviors, in schizophrenia. In PV neuron-specific GAD67 knockout mice, increased levels of PV, BDNF, and KCNS3 mRNAs might be the consequence of increased neuronal activity secondary to lower GABA synthesis, whereas increased GAD65 mRNA might represent a compensatory response to increase GABA synthesis.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cerebral cortex; in situ hybridization; mouse; prepulse inhibition; schizophrenia; working memory

Mesh:

Substances:

Year:  2016        PMID: 26980143      PMCID: PMC4903066          DOI: 10.1093/schbul/sbw022

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  61 in total

1.  Target-specific effects of somatostatin-expressing interneurons on neocortical visual processing.

Authors:  James C H Cottam; Spencer L Smith; Michael Häusser
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

2.  The expression pattern of somatostatin and calretinin by postnatal hippocampal interneurons is regulated by activity-dependent and -independent determinants.

Authors:  S Marty; B Onténiente
Journal:  Neuroscience       Date:  1997-09       Impact factor: 3.590

3.  Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus.

Authors:  Martin Vreugdenhil; John G R Jefferys; Marco R Celio; Beat Schwaller
Journal:  J Neurophysiol       Date:  2003-03       Impact factor: 2.714

Review 4.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

5.  Modulation of behavioral networks by selective interneuronal inactivation.

Authors:  M J Schmidt; S Horvath; P Ebert; J L Norris; E H Seeley; J Brown; L Gellert; M Everheart; K A Garbett; T W Grice; R M Caprioli; K Mirnics
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

6.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

7.  GABAA receptor subunit immunoreactivity in primate visual cortex: distribution in macaques and humans and regulation by visual input in adulthood.

Authors:  S H Hendry; M M Huntsman; A Viñuela; H Möhler; A L de Blas; E G Jones
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

8.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

Authors:  S Akbarian; M M Huntsman; J J Kim; A Tafazzoli; S G Potkin; W E Bunney; E G Jones
Journal:  Cereb Cortex       Date:  1995 Nov-Dec       Impact factor: 5.357

9.  Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.

Authors:  Nikolaos Mellios; Hsien-Sung Huang; Stephen P Baker; Marzena Galdzicka; Edward Ginns; Schahram Akbarian
Journal:  Biol Psychiatry       Date:  2009-01-01       Impact factor: 13.382

10.  Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.

Authors:  M T Ray; C Shannon Weickert; M J Webster
Journal:  Transl Psychiatry       Date:  2014-05-06       Impact factor: 6.222

View more
  13 in total

1.  The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.

Authors:  Stephan F Taylor; Tyler B Grove; Vicki L Ellingrod; Ivy F Tso
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

2.  Structural alterations in fast-spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis.

Authors:  Feng Gu; Isabel Parada; Fran Shen; Judith Li; Alberto Bacci; Kevin Graber; Reza Moein Taghavi; Karina Scalise; Philip Schwartzkroin; Jurgen Wenzel; David A Prince
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

3.  GABA and schizophrenia: Where we stand and where we need to go.

Authors:  Jill R Glausier; David A Lewis
Journal:  Schizophr Res       Date:  2017-02-05       Impact factor: 4.939

Review 4.  Cognitive Dysfunction and Prefrontal Cortical Circuit Alterations in Schizophrenia: Developmental Trajectories.

Authors:  Samuel J Dienel; Kirsten E Schoonover; David A Lewis
Journal:  Biol Psychiatry       Date:  2022-03-10       Impact factor: 12.810

5.  Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.

Authors:  Daniel W Chung; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-07-22       Impact factor: 18.112

Review 6.  Alterations in cortical interneurons and cognitive function in schizophrenia.

Authors:  Samuel J Dienel; David A Lewis
Journal:  Neurobiol Dis       Date:  2018-06-22       Impact factor: 5.996

7.  Kcns3 deficiency disrupts Parvalbumin neuron physiology in mouse prefrontal cortex: Implications for the pathophysiology of schizophrenia.

Authors:  Takeaki Miyamae; Takanori Hashimoto; Monica Abraham; Rika Kawabata; Sho Koshikizawa; Yufan Bian; Yosuke Nishihata; Mitsuru Kikuchi; G Bard Ermentrout; David A Lewis; Guillermo Gonzalez-Burgos
Journal:  Neurobiol Dis       Date:  2021-04-30       Impact factor: 5.996

8.  Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus.

Authors:  Stefan M Kolata; Kazuhito Nakao; Vivek Jeevakumar; Emily L Farmer-Alroth; Yuko Fujita; Aundrea F Bartley; Sunny Zhihong Jiang; Gregory R Rompala; Robert E Sorge; Dennisse V Jimenez; Keri Martinowich; Yolanda Mateo; Kenji Hashimoto; Lynn E Dobrunz; Kazu Nakazawa
Journal:  Neuropsychopharmacology       Date:  2017-12-06       Impact factor: 7.853

Review 9.  Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics.

Authors:  Mary-Anne B MacKay; John W Paylor; James T F Wong; Ian R Winship; Glen B Baker; Serdar M Dursun
Journal:  Front Psychiatry       Date:  2018-10-30       Impact factor: 4.157

10.  Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia.

Authors:  Ryan Shepard; Kelsey Heslin; Payton Hagerdorn; Laurence Coutellier
Journal:  Transl Psychiatry       Date:  2019-02-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.